CSS
TARO

Cubist Systematic Strategies’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Cubist Systematic Strategies’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25
Closed -$2K – 3150
2021
Q1 		$2K Buy
+25
New +$1.9K ﹤0.01% 2798
2019
Q4 		– Sell
-2,698
Closed -$204K – 2585
2019
Q3 		$204K Sell
2,698
-1,385
-34% -$112K ﹤0.01% 1764
2019
Q2 		$349K Buy
4,083
+1,556
+62% +$154K 0.01% 1700
2019
Q1 		$273K Buy
2,527
+64
+3% +$6.37K 0.01% 1569
2018
Q4 		$208K Buy
2,463
+309
+14% +$29.8K 0.01% 1509
2018
Q3 		$212K Sell
2,154
-1,968
-48% -$213K 0.01% 1384
2018
Q2 		$477K Sell
4,122
-696
-14% -$76.5K 0.02% 812
2018
Q1 		$476K Sell
4,818
-5,555
-54% -$563K 0.03% 825
2017
Q4 		$1.09M Buy
+10,373
New +$1.14M 0.06% 437
2016
Q2 		– Sell
-2,173
Closed -$311K – 1924
2016
Q1 		$311K Sell
2,173
-600
-22% -$85.2K 0.02% 961
2015
Q4 		$429K Sell
2,773
-1,412
-34% -$206K 0.03% 905
2015
Q3 		$598K Buy
4,185
+2,238
+115% +$313K 0.03% 853
2015
Q2 		$280K Sell
1,947
-2,963
-60% -$423K 0.01% 1254
2015
Q1 		$692K Sell
4,910
-272
-5% -$41.9K 0.03% 753
2014
Q4 		$768K Buy
5,182
+3,011
+139% +$442K 0.04% 631
2014
Q3 		$334K Buy
+2,171
New +$327K 0.02% 1047

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cubist Systematic Strategies's TARO Position: Q2 2021 in Review

Cubist Systematic Strategies sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021, closing a stake of 25 shares — an estimated $2K sold.

Cubist Systematic Strategies first reported a position in TARO in Q3 2014 and held it in 16 quarters. The position peaked at $1.09M in Q4 2017. 76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

  • Cubist Systematic Strategies reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 25 Taro Pharmaceutical Industries Ltd. shares in Q2 2021, an estimated $2K.
  • Cubist Systematic Strategies first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 16 quarters.
  • Cubist Systematic Strategies's Taro Pharmaceutical Industries Ltd. position peaked at $1.09M in Q4 2017.
  • 76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.